CVSI - CV Sciences, Inc.
0.0272
0.000 0.368%
Share volume: 102,823
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.03
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-14-2024 | 03-27-2025 | |
| Total revenue | 3.865 M | 3.884 M | |
| Cost of revenue | 2.087 M | 2.207 M | |
| Gross profit | 1.778 M | 1.677 M | |
| -5.68% | |||
| Operating expenses | 2.119 M | 2.323 M | |
| Selling general and admin | 2.090 M | 2.298 M | |
| Research and development | 29.000 K | 25.000 K | |
| Total expenses | 2.119 M | 2.323 M | |
| 9.63% | |||
| Operating income | -341.000 K | -646.000 K | |
| Ebit | -456.000 K | -740.000 K | |
| Pretax income | -456.000 K | -740.000 K | |
| 62.28% | |||
| Income tax | 0.000 | -14.000 K | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -456.000 K | -726.000 K | |
| -59.21% |
